{
    "2021-08-11": [
        [
            {
                "time": "2021-08-11",
                "original_text": "A股早报2021年8月11日星期三",
                "features": {
                    "keywords": [
                        "A股",
                        "早报",
                        "2021年8月11日"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-07-27",
                "original_text": "华兰生物：7月27日，公司首批200万支四价流感疫苗发往河南等地",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "四价流感疫苗",
                        "河南"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华兰生物：目前公司和广东恩宝已启动相关疫苗的临床试验相关工作",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "广东恩宝",
                        "临床试验",
                        "疫苗"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "市场格局加速重塑，谁将成为中国的“疫苗之王”？",
                "features": {
                    "keywords": [
                        "市场格局",
                        "疫苗之王"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "华兰生物：目前公司的所有产品均未列入医保集采",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "医保集采"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}